肌萎缩
医学
重症监护医学
心理干预
老年学
内科学
肌肉团
精神科
作者
Alfonso J. Cruz‐Jentoft,Avan Aihie Sayer
出处
期刊:The Lancet
[Elsevier BV]
日期:2019-06-01
卷期号:393 (10191): 2636-2646
被引量:2593
标识
DOI:10.1016/s0140-6736(19)31138-9
摘要
Summary
Sarcopenia is a progressive and generalised skeletal muscle disorder involving the accelerated loss of muscle mass and function that is associated with increased adverse outcomes including falls, functional decline, frailty, and mortality. It occurs commonly as an age-related process in older people, influenced not only by contemporaneous risk factors, but also by genetic and lifestyle factors operating across the life course. It can also occur in mid-life in association with a range of conditions. Sarcopenia has become the focus of intense research aiming to translate current knowledge about its pathophysiology into improved diagnosis and treatment, with particular interest in the development of biomarkers, nutritional interventions, and drugs to augment the beneficial effects of resistance exercise. Designing effective preventive strategies that people can apply during their lifetime is of primary concern. Diagnosis, treatment, and prevention of sarcopenia is likely to become part of routine clinical practice.
科研通智能强力驱动
Strongly Powered by AbleSci AI